 | • レポートコード：MRC2-11QY13571 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は急性脊髄損傷のグローバル市場について調査・分析したレポートです。種類別（実験室検査、画像検査）市場規模、用途別（病院、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別急性脊髄損傷の競争状況、市場シェア ・世界の急性脊髄損傷市場：種類別市場規模 2015年-2020年（実験室検査、画像検査） ・世界の急性脊髄損傷市場：種類別市場規模予測 2021年-2026年（実験室検査、画像検査） ・世界の急性脊髄損傷市場：用途別市場規模 2015年-2020年（病院、診療所） ・世界の急性脊髄損傷市場：用途別市場規模予測 2021年-2026年（病院、診療所） ・北米の急性脊髄損傷市場分析：米国、カナダ ・ヨーロッパの急性脊髄損傷市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの急性脊髄損傷市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の急性脊髄損傷市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの急性脊髄損傷市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Oxygen Biotherapeutics、BioAxone BioSciences、AOSpine International、Neuronax、K-Stemcell、Asterias Biotherapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Acute spinal cord injury (SCI) is a clinical condition caused due to a painful injury that result in a contusion or bruise to a fractional or complete spinal cord resulting into permanent disability and/or death in adults and children.
The treatment of acute spinal cord injury is dependent on few factors such as age, health, medical history, severity of spinal cord injury, type of spinal cord injury and extent of psychological recovery. The treatment regime of acute spinal cord injury consists of medical management and observation in intensive care unit (ICU), corticosteroids to decrease the swelling, mechanical ventilator, bladder catheter and feeding tube. The treatments available against acute spinal cord injury are anterior cervical discectomy (ACDF), total disc arthroplasty, cervical laminoplasty, posterior aminotomy microdiscectomy, lumbar decompression, lumbar fusion and kyphoplasty.
Market Analysis and Insights: Global Acute Spinal Cord Injury Market
The global Acute Spinal Cord Injury market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Acute Spinal Cord Injury Scope and Market Size
Acute Spinal Cord Injury market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Spinal Cord Injury market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novartis
Oxygen Biotherapeutics
BioAxone BioSciences
AOSpine International
Neuronax
K-Stemcell
Asterias Biotherapeutics
…
Market segment by Type, the product can be split into
Laboratory Tests
Imaging Tests
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Spinal Cord Injury Revenue
1.4 Market by Type
1.4.1 Global Acute Spinal Cord Injury Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Laboratory Tests
1.4.3 Imaging Tests
1.5 Market by Application
1.5.1 Global Acute Spinal Cord Injury Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Acute Spinal Cord Injury Market Perspective (2015-2026)
2.2 Global Acute Spinal Cord Injury Growth Trends by Regions
2.2.1 Acute Spinal Cord Injury Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Spinal Cord Injury Historic Market Share by Regions (2015-2020)
2.2.3 Acute Spinal Cord Injury Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acute Spinal Cord Injury Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Spinal Cord Injury Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Acute Spinal Cord Injury Players by Market Size
3.1.1 Global Top Acute Spinal Cord Injury Players by Revenue (2015-2020)
3.1.2 Global Acute Spinal Cord Injury Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Spinal Cord Injury Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Spinal Cord Injury Market Concentration Ratio
3.2.1 Global Acute Spinal Cord Injury Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Spinal Cord Injury Revenue in 2019
3.3 Acute Spinal Cord Injury Key Players Head office and Area Served
3.4 Key Players Acute Spinal Cord Injury Product Solution and Service
3.5 Date of Enter into Acute Spinal Cord Injury Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Acute Spinal Cord Injury Historic Market Size by Type (2015-2020)
4.2 Global Acute Spinal Cord Injury Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Acute Spinal Cord Injury Market Size by Application (2015-2020)
5.2 Global Acute Spinal Cord Injury Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Acute Spinal Cord Injury Market Size (2015-2020)
6.2 Acute Spinal Cord Injury Key Players in North America (2019-2020)
6.3 North America Acute Spinal Cord Injury Market Size by Type (2015-2020)
6.4 North America Acute Spinal Cord Injury Market Size by Application (2015-2020)
7 Europe
7.1 Europe Acute Spinal Cord Injury Market Size (2015-2020)
7.2 Acute Spinal Cord Injury Key Players in Europe (2019-2020)
7.3 Europe Acute Spinal Cord Injury Market Size by Type (2015-2020)
7.4 Europe Acute Spinal Cord Injury Market Size by Application (2015-2020)
8 China
8.1 China Acute Spinal Cord Injury Market Size (2015-2020)
8.2 Acute Spinal Cord Injury Key Players in China (2019-2020)
8.3 China Acute Spinal Cord Injury Market Size by Type (2015-2020)
8.4 China Acute Spinal Cord Injury Market Size by Application (2015-2020)
9 Japan
9.1 Japan Acute Spinal Cord Injury Market Size (2015-2020)
9.2 Acute Spinal Cord Injury Key Players in Japan (2019-2020)
9.3 Japan Acute Spinal Cord Injury Market Size by Type (2015-2020)
9.4 Japan Acute Spinal Cord Injury Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Acute Spinal Cord Injury Market Size (2015-2020)
10.2 Acute Spinal Cord Injury Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Spinal Cord Injury Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Spinal Cord Injury Market Size by Application (2015-2020)
11 India
11.1 India Acute Spinal Cord Injury Market Size (2015-2020)
11.2 Acute Spinal Cord Injury Key Players in India (2019-2020)
11.3 India Acute Spinal Cord Injury Market Size by Type (2015-2020)
11.4 India Acute Spinal Cord Injury Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Acute Spinal Cord Injury Market Size (2015-2020)
12.2 Acute Spinal Cord Injury Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Spinal Cord Injury Market Size by Type (2015-2020)
12.4 Central & South America Acute Spinal Cord Injury Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Acute Spinal Cord Injury Introduction
13.1.4 Novartis Revenue in Acute Spinal Cord Injury Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Oxygen Biotherapeutics
13.2.1 Oxygen Biotherapeutics Company Details
13.2.2 Oxygen Biotherapeutics Business Overview
13.2.3 Oxygen Biotherapeutics Acute Spinal Cord Injury Introduction
13.2.4 Oxygen Biotherapeutics Revenue in Acute Spinal Cord Injury Business (2015-2020)
13.2.5 Oxygen Biotherapeutics Recent Development
13.3 BioAxone BioSciences
13.3.1 BioAxone BioSciences Company Details
13.3.2 BioAxone BioSciences Business Overview
13.3.3 BioAxone BioSciences Acute Spinal Cord Injury Introduction
13.3.4 BioAxone BioSciences Revenue in Acute Spinal Cord Injury Business (2015-2020)
13.3.5 BioAxone BioSciences Recent Development
13.4 AOSpine International
13.4.1 AOSpine International Company Details
13.4.2 AOSpine International Business Overview
13.4.3 AOSpine International Acute Spinal Cord Injury Introduction
13.4.4 AOSpine International Revenue in Acute Spinal Cord Injury Business (2015-2020)
13.4.5 AOSpine International Recent Development
13.5 Neuronax
13.5.1 Neuronax Company Details
13.5.2 Neuronax Business Overview
13.5.3 Neuronax Acute Spinal Cord Injury Introduction
13.5.4 Neuronax Revenue in Acute Spinal Cord Injury Business (2015-2020)
13.5.5 Neuronax Recent Development
13.6 K-Stemcell
13.6.1 K-Stemcell Company Details
13.6.2 K-Stemcell Business Overview
13.6.3 K-Stemcell Acute Spinal Cord Injury Introduction
13.6.4 K-Stemcell Revenue in Acute Spinal Cord Injury Business (2015-2020)
13.6.5 K-Stemcell Recent Development
13.7 Asterias Biotherapeutics
13.7.1 Asterias Biotherapeutics Company Details
13.7.2 Asterias Biotherapeutics Business Overview
13.7.3 Asterias Biotherapeutics Acute Spinal Cord Injury Introduction
13.7.4 Asterias Biotherapeutics Revenue in Acute Spinal Cord Injury Business (2015-2020)
13.7.5 Asterias Biotherapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Acute Spinal Cord Injury Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Spinal Cord Injury Revenue
Table 3. Ranking of Global Top Acute Spinal Cord Injury Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Spinal Cord Injury Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Laboratory Tests
Table 6. Key Players of Imaging Tests
Table 7. Global Acute Spinal Cord Injury Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Acute Spinal Cord Injury Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Acute Spinal Cord Injury Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Acute Spinal Cord Injury Market Share by Regions (2015-2020)
Table 11. Global Acute Spinal Cord Injury Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Acute Spinal Cord Injury Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Acute Spinal Cord Injury Market Growth Strategy
Table 17. Main Points Interviewed from Key Acute Spinal Cord Injury Players
Table 18. Global Acute Spinal Cord Injury Revenue by Players (2015-2020) (Million US$)
Table 19. Global Acute Spinal Cord Injury Market Share by Players (2015-2020)
Table 20. Global Top Acute Spinal Cord Injury Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Spinal Cord Injury as of 2019)
Table 21. Global Acute Spinal Cord Injury by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Acute Spinal Cord Injury Product Solution and Service
Table 24. Date of Enter into Acute Spinal Cord Injury Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Spinal Cord Injury Market Size by Type (2015-2020) (Million US$)
Table 27. Global Acute Spinal Cord Injury Market Size Share by Type (2015-2020)
Table 28. Global Acute Spinal Cord Injury Revenue Market Share by Type (2021-2026)
Table 29. Global Acute Spinal Cord Injury Market Size Share by Application (2015-2020)
Table 30. Global Acute Spinal Cord Injury Market Size by Application (2015-2020) (Million US$)
Table 31. Global Acute Spinal Cord Injury Market Size Share by Application (2021-2026)
Table 32. North America Key Players Acute Spinal Cord Injury Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Acute Spinal Cord Injury Market Share (2019-2020)
Table 34. North America Acute Spinal Cord Injury Market Size by Type (2015-2020) (Million US$)
Table 35. North America Acute Spinal Cord Injury Market Share by Type (2015-2020)
Table 36. North America Acute Spinal Cord Injury Market Size by Application (2015-2020) (Million US$)
Table 37. North America Acute Spinal Cord Injury Market Share by Application (2015-2020)
Table 38. Europe Key Players Acute Spinal Cord Injury Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Acute Spinal Cord Injury Market Share (2019-2020)
Table 40. Europe Acute Spinal Cord Injury Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Acute Spinal Cord Injury Market Share by Type (2015-2020)
Table 42. Europe Acute Spinal Cord Injury Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Acute Spinal Cord Injury Market Share by Application (2015-2020)
Table 44. China Key Players Acute Spinal Cord Injury Revenue (2019-2020) (Million US$)
Table 45. China Key Players Acute Spinal Cord Injury Market Share (2019-2020)
Table 46. China Acute Spinal Cord Injury Market Size by Type (2015-2020) (Million US$)
Table 47. China Acute Spinal Cord Injury Market Share by Type (2015-2020)
Table 48. China Acute Spinal Cord Injury Market Size by Application (2015-2020) (Million US$)
Table 49. China Acute Spinal Cord Injury Market Share by Application (2015-2020)
Table 50. Japan Key Players Acute Spinal Cord Injury Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Acute Spinal Cord Injury Market Share (2019-2020)
Table 52. Japan Acute Spinal Cord Injury Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Acute Spinal Cord Injury Market Share by Type (2015-2020)
Table 54. Japan Acute Spinal Cord Injury Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Acute Spinal Cord Injury Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Acute Spinal Cord Injury Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Acute Spinal Cord Injury Market Share (2019-2020)
Table 58. Southeast Asia Acute Spinal Cord Injury Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Acute Spinal Cord Injury Market Share by Type (2015-2020)
Table 60. Southeast Asia Acute Spinal Cord Injury Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Acute Spinal Cord Injury Market Share by Application (2015-2020)
Table 62. India Key Players Acute Spinal Cord Injury Revenue (2019-2020) (Million US$)
Table 63. India Key Players Acute Spinal Cord Injury Market Share (2019-2020)
Table 64. India Acute Spinal Cord Injury Market Size by Type (2015-2020) (Million US$)
Table 65. India Acute Spinal Cord Injury Market Share by Type (2015-2020)
Table 66. India Acute Spinal Cord Injury Market Size by Application (2015-2020) (Million US$)
Table 67. India Acute Spinal Cord Injury Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Acute Spinal Cord Injury Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Acute Spinal Cord Injury Market Share (2019-2020)
Table 70. Central & South America Acute Spinal Cord Injury Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Acute Spinal Cord Injury Market Share by Type (2015-2020)
Table 72. Central & South America Acute Spinal Cord Injury Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Acute Spinal Cord Injury Market Share by Application (2015-2020)
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Product
Table 77. Novartis Revenue in Acute Spinal Cord Injury Business (2015-2020) (Million US$)
Table 78. Novartis Recent Development
Table 79. Oxygen Biotherapeutics Company Details
Table 80. Oxygen Biotherapeutics Business Overview
Table 81. Oxygen Biotherapeutics Product
Table 82. Oxygen Biotherapeutics Revenue in Acute Spinal Cord Injury Business (2015-2020) (Million US$)
Table 83. Oxygen Biotherapeutics Recent Development
Table 84. BioAxone BioSciences Company Details
Table 85. BioAxone BioSciences Business Overview
Table 86. BioAxone BioSciences Product
Table 87. BioAxone BioSciences Revenue in Acute Spinal Cord Injury Business (2015-2020) (Million US$)
Table 88. BioAxone BioSciences Recent Development
Table 89. AOSpine International Company Details
Table 90. AOSpine International Business Overview
Table 91. AOSpine International Product
Table 92. AOSpine International Revenue in Acute Spinal Cord Injury Business (2015-2020) (Million US$)
Table 93. AOSpine International Recent Development
Table 94. Neuronax Company Details
Table 95. Neuronax Business Overview
Table 96. Neuronax Product
Table 97. Neuronax Revenue in Acute Spinal Cord Injury Business (2015-2020) (Million US$)
Table 98. Neuronax Recent Development
Table 99. K-Stemcell Company Details
Table 100. K-Stemcell Business Overview
Table 101. K-Stemcell Product
Table 102. K-Stemcell Revenue in Acute Spinal Cord Injury Business (2015-2020) (Million US$)
Table 103. K-Stemcell Recent Development
Table 104. Asterias Biotherapeutics Company Details
Table 105. Asterias Biotherapeutics Business Overview
Table 106. Asterias Biotherapeutics Product
Table 107. Asterias Biotherapeutics Revenue in Acute Spinal Cord Injury Business (2015-2020) (Million US$)
Table 108. Asterias Biotherapeutics Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Spinal Cord Injury Market Share by Type: 2020 VS 2026
Figure 2. Laboratory Tests Features
Figure 3. Imaging Tests Features
Figure 4. Global Acute Spinal Cord Injury Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Acute Spinal Cord Injury Report Years Considered
Figure 8. Global Acute Spinal Cord Injury Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Acute Spinal Cord Injury Market Share by Regions: 2020 VS 2026
Figure 10. Global Acute Spinal Cord Injury Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Acute Spinal Cord Injury Market Share by Players in 2019
Figure 13. Global Top Acute Spinal Cord Injury Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Spinal Cord Injury as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Acute Spinal Cord Injury Revenue in 2019
Figure 15. North America Acute Spinal Cord Injury Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Acute Spinal Cord Injury Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Acute Spinal Cord Injury Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Acute Spinal Cord Injury Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Acute Spinal Cord Injury Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Acute Spinal Cord Injury Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Acute Spinal Cord Injury Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
脊髄刺激システムの世界市場（～2026年） The spinal cord stimulation system is also known as a neurostimulation system which provides the therapeutic treatment of the chronic back, neck and extremity pain. The increasing prevalence of chronic and neuropathic pain disorders and the increasing technological advancements to the spinal cord st…- 転移性脊椎腫瘍の世界市場（～2026年） A spine tumor is an abnormal growth of tissue found in and/or around the spinal column and/or spinal cord. More than 95% of all metastatic spinal tumors are found outside the dura (extradural) and within the vertebral body, and in more than half of the cases they are found on multiple levels of the …
- 脊椎画像の世界市場（～2026年） Market Analysis and Insights: Global Spinal Imaging Market The global Spinal Imaging market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
- 脊椎画像ガイダンスシステムの世界市場（～2026年） Spinal image guidance systems are used for the detailed view spinal surgeries. The global market for spinal image guidance system market is expected to be driven by the increasing number of experienced practitioners, awareness among the population to several new advanced technologies. Market Analysi…
- 変形性脊椎システムの世界市場（～2026年） The deformity spinal system is an implant system which is used to correct spinal deformity and facilitate the biological process of spinal fusion. The deformity spinal system is a spinal screw and rod system. As deformity spinal system includes fixed and polyaxial screws of various lengths and diame…